Company · CIK 0001802768 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Royalty Pharma plc · RPRX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 SForm 4 → | Sep 24, 4:10 pm EDT | Christopher HiteEVP & Chairman, Partnering | 100,000 | $58.53 | $5,853,095 | 270,401 | −27.0% | 10b5-1 |
| Aug 19, 2026 GForm 4 → | Aug 19, 4:20 pm EDT | Christopher HiteEVP & Chairman, Partnering | 16,800 | — | — | 23,200 | — | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 19, 4:20 pm EDT | Christopher HiteEVP & Chairman, Partnering | 100,000 | $59.97 | $5,997,250 | 370,401 | −21.3% | 10b5-1 |
| Aug 13, 2026 SForm 4 → | Aug 17, 5:01 pm EDT | Terrance P. CoyneEVP & CFO | 11,002 | $58.68 | $645,551 | 0 | −100% | 10b5-1 |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:24 pm EDT | Pablo G. LegorretaCEO, Chairman of the Board, Director | 65,216 | — | — | 1,307,820 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:24 pm EDT | Terrance P. CoyneEVP & CFO | 11,002 | — | — | 11,002 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:12 pm EDT | Christopher HiteEVP & Chairman, Partnering | 11,002 | — | — | 470,401 | — | |
| Aug 5, 2026 AForm 4 → | Aug 7, 5:11 pm EDT | Marshall UristEVP, Research & Investments | 8,252 | — | — | 8,252 | — | |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:10 pm EDT | Marshall UristEVP, Research & Investments | 9,099 | $55.88 | $508,454 | 0 | −100% | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:08 pm EDT | Christopher HiteEVP & Chairman, Partnering | 130,000 | $56.50 | $7,345,471 | 40,000 | −76.5% | 10b5-1 |
| Jun 30, 2026 AForm 4 → | Jun 30, 5:15 pm EDT | Bonnie L BasslerDirector | 689 | $54.40 | $37,481 | 79,181 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 GForm 4 → | Aug 7, 5:24 pm EDT | Pablo G. LegorretaCEO, Chairman of the Board, Director | 30,000 | — | — | 662,701 | — | |
| Aug 7, 2026 GForm 4 → | Aug 7, 5:24 pm EDT | Terrance P. CoyneEVP & CFO | 18,500 | — | — | 1,788,777 | — | |
| Aug 7, 2026 GForm 4 → | Aug 7, 5:11 pm EDT | Marshall UristEVP, Research & Investments | 3,000 | — | — | 244,412 | — |